1. TYRA-200: Potent Against FGFR2 Fusions, Molecular Brake Mutations and Gatekeeper Resistance. (October 2022) Authors: Allen, E.; Balcer, A.; Bensen, D.; Burn, T.; Hoffman, I.; Hudkins, R.; Iyer, S.; Neal, M.; Nelson, K.; Occhino, C.; Patel, P.; Starrett, J.; Swanson, R.; Ye, Q. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials. (15th July 2016) Authors: Langley, R.G.B.; Cohen, A.D.; Foley, P.; Griffiths, C.E.M.; Lebwohl, M.; Leonardi, C.; Winthrop, K.; Proulx, J.; Rottinghaus, S.T.; Wolk, R.; Thompson, J.R.; Tatulych, S.; Mallbris, L.; Swanson, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗